Key result
Selective M3-cholinoreceptor activation suppresses ventricular repolarization and Ca2+ currents in young but not ageing rats.
Why the study?
Ageing affects all systems of the organism and changes the cardiac environment, but ageing-related changes in parasympathetic regulation mechanisms of the mammalian heart remained to be demonstrated.
p-value: p=<0.05
Ageing is associated with down-regulation of cardiac M3 receptors and a loss of M3-mediated action potential shortening, which may contribute to proarrhythmic risk in the ageing heart.
Age-related M3 down-regulation may heighten proarrhythmic risk; leaves open whether M3-targeted therapies could mitigate age-related arrhythmias.
Ageing is a complex process which affects all systems of the organism and therefore changes the environment where the heart is working. In this study we demonstrate the ageing-related changes in the mechanisms of parasympathetic regulation of mammalian heart. Electrophysiological effects produced by selective activation of M3-cholinoreceptors were compared in isolated cardiac preparations from young adult (4 months), adult (1 year) and ageing (2 years) rats using sharp glass microelectrode technique. M3-receptors were activated with muscarinic agonist pilocarpine (10-5M) in the presence of selective M2 antagonist AQ-RA741 (10-7M). In atrial and ventricular myocardium from young rats M3 stimulation induced shortening of action potentials(APs), while no significant effect was observed in both elder groups. The main mechanism of M3-induced AP shortening is inhibition of L-type Ca2+ current, estimated using whole-cell patch-clamp. It was negligible in atrial myocytes from ageing animals in comparison with young rats. The loss of sensitivity to stimulation of M3-receptors is due to decrease in M3 gene expression, shown by RT-PCR both in atrial and ventricular samples from ageing rats. Thus, in ageing rat heart M3-receptors are down-regulated and not involved in regulation of electrical activity.
No takes yet. Share an insight, caveat, or question.
Tapilina et al. (2021) studied Ageing. M3-cholinoreceptor activation (pilocarpine) vs. Baseline (Intragroup) and Young vs Ageing rats was evaluated on Action potential (AP) duration and L-type Ca2+ current inhibition (p=<0.05). Selective M3-cholinoreceptor activation shortened action potentials and suppressed L-type Ca2+ currents in young rats, but these effects were absent in ageing rats due to down-regulation of M3 gene expression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: